AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2020
Jan 9, 2020
32464_dirs_2020-01-08_7ca8e70a-d50c-4d9a-96b8-55488b451091.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2020-01-06
Reporting Person: Thomas Steffen (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-06 | Stock Option (Right to Buy) | $2.96 | A | 50000 | Acquired | 2030-01-06 | Common Stock (50000) | Direct |
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25